I am pleased with the overall strong performance of our business in the third quarter, particularly the dynamic growth of Pharmaceuticals.
We are confident of delivering in 2006 another year of dynamic growth with record sales and earnings.
Looking ahead, we anticipate a somewhat softer third quarter and, again, a more dynamic fourth quarter resulting in mid-single-digit sales growth... and solid operating growth for the full year,